Drug Profile
Research programme: respiratory disorder therapeutics - Ipsen Bioinnovation
Alternative Names: SXN 100187; SXN 187Latest Information Update: 17 Jul 2015
Price :
$50
*
At a glance
- Originator Syntaxin
- Class Bacterial toxins; Botulinum toxins; Endopeptidases; Recombinant fusion proteins
- Mechanism of Action Mucin inhibitors; SNARE protein antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Bronchitis; Chronic obstructive pulmonary disease; Cystic fibrosis